Interpretation (Health Sciences Authority Act — Fees) Order 2017

Status:

Not current version
(version history — see timeline)

No. S 577

Interpretation Act

(CHAPTER 1)

Interpretation
(Health Sciences Authority Act — Fees)
Order 2017

In exercise of the powers conferred by section 46(1) of the Interpretation Act, the Minister for Health makes the following Order:

Citation and commencement

1. This Order is the Interpretation (Health Sciences Authority Act — Fees) Order 2017 and comes into operation on 11 October 2017.

Definitions

2. In this Order —

“Authority” means the Health Sciences Authority established under section 3 of the Health Sciences Authority Act 2001;

[S 488/2024 wef 31/12/2021]

“cell, tissue or gene therapy product” means a health product categorised as a cell, tissue or gene therapy product in the First Schedule to the Health Products Act 2007;

[S 102/2021 wef 01/03/2021]

[S 488/2024 wef 31/12/2021]

“medical device” means a health product categorised as a medical device in the First Schedule to the Health Products Act 2007.

[S 488/2024 wef 31/12/2021]

Fees for consultancy services

3. The fees specified in the second column of the Schedule are payable to the Authority for the consultancy services under section 12(d) of the Health Sciences Authority Act 2001 specified opposite in the first column.

[S 488/2024 wef 31/12/2021]

Made on 5 October 2017.

CHAN HENG KEE

Permanent Secretary,
Ministry of Health,
Singapore.

[HSA/LPPD/2017:08; AG/LEGIS/SL/1/2015/7 Vol. 1]

Search within Legislation